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Squamous cell carcinomas (SCC) derived from human
epidermis fail to differentiate normally under the influ-
ence of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] despite
the presence of the vitamin D receptor. Previous studies
from our laboratory showed that phospholipase C-γ1
(PLC-γ1) was upregulated transcriptionally by
1,25(OH)2D3 in normal human keratinocytes, and a vit-
amin D responsive element (VDRE) in its promoter
region has been identified. To examine the inducibility
of human PLC-γ1 transcription by 1,25(OH)2D3 and/or
retinoic acid in SCC cell lines, we transiently transfected
SCC4 and SCC12B2 cells with human PLC-γ1 promoter-
luciferase constructs containing the VDRE and tested the
response of these constructs to 1,25(OH)2D3 and/or all-
trans retinoic acid. The induction of the human PLC-γ1
VDRE by 1,25(OH)2D3 was synergistic with all-trans
retinoic acid in normal human keratinocytes, but none
of the constructs was induced by 1,25(OH)2D3 and/or
Phospholipase C (PLC) is a family of isoenzymes thathydrolyzes phosphatidylinositol-4,5-bisphosphate into twosecond messengers, inositol-1,4,5-triphosphate and diacyl-glycerol (Rhee et al, 1989; Majerus et al, 1990). Diacylgly-cerol is the physiologic activator of protein kinase C
(PKC), and inositol triphosphate induces the release of calcium from
internal storage (Berridge and Irvine, 1989). Calcium mobilization and
PKC activation are essential for many cellular processes, such as cell
proliferation and differentiation (Rana and Hokin, 1990). Several
distinct PLC isoenzymes have been purified from several mammalian
tissues, and several forms have been molecularly cloned. Comparison
of the deduced amino acid sequences has indicated that PLC are
divided into three types (PLC-β, PLC-γ, and PLC-δ), and each type
contains several subtypes (Rhee et al, 1989, 1992). PLC-γ1 has attracted
the most attention because PLC-γ1 is activated by the growth factors
with intrinsic tyrosine kinase activity, such as platelet derived growth
factor (Wahl et al, 1989), epidermal growth factor (Margolis et al, 1989;
Meisenhelder et al, 1989), fibroblast growth factor (Burgess et al, 1990),
and nerve growth factor (Kim et al, 1991). PLC-γ1 is overexpressed
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all-trans retinoic acid in SCC4 and SCC12B2 cells. In
contrast, the construct containing the VDRE of the
human 24-hydroxylase gene was induced several fold by
1,25(OH)2D3 in normal human keratinocytes and by both
1,25(OH)2D3 and all-trans retinoic acid in SCC4 and
SCC12B2 cells. DNA mobility shift assays showed that
both the vitamin D receptor and the retinoic acid receptor
in SCC4 and SCC12B2 cells bound the human PLC-γ1
VDRE similarly to that seen in normal keratinocytes.
The data indicate that the VDRE in the human PLC-γ1
gene is not functional in SCC4 and SCC12B2 cells, unlike
normal human keratinocytes, even though vitamin D
receptors bind normally to it. Failure of transcriptional
control of the PLC-γ1 gene by 1,25(OH)2D3 suggests the
lack of a cofactor(s) linking the VDRE to the transcrip-
tional machinery. Key words: all-trans retinoic acid/1,25-
dihydroxyvitamin D/phospholipase C-γ1/24-hydroxylase. J
Invest Dermatol 110:730–733, 1998
in primary human breast carcinoma (Arteaga et al, 1991), human
colorectal cancer (Park et al, 1994), familial adenomatous polyposis
(Noh et al, 1994), and hyperproliferative epidermal diseases (Nanney
et al, 1992). The amount of PLC-γ1 protein is higher in neoplastic
keratinocyte cell lines than in normal keratinocytes (NHK) (Punnonen
et al, 1994). Differentiating keratinocytes express more PLC-γ1 protein
than undifferentiated keratinocytes (Punnonen et al, 1993). These
observations suggest that PLC-γ1 might be involved in the regulation
of cell proliferation and differentiation.
NHK differentiation is induced by 1,25-dihydroxyvitamin D3
[1,25(OH)2D3] (Hosomi et al, 1983; Smith et al, 1986; Bikle and Pillai,
1993; Bikle et al, 1993). The mechanism by which 1,25(OH)2D3
induces keratinocyte differentiation is thought to include changes in
intracellular calcium, PLC, and PKC activation. PLC-γ1 in NHK is
upregulated by 1,25(OH)2D (Pillai et al, 1995). This regulation takes
place at the transcriptional level, and we have recently identified a
vitamin D responsive element (VDRE) at –786 bp to –803 bp in the
human PLC-γ1 promoter region (Xie and Bikle, 1997). In contrast,
several of the squamous cell carcinoma (SCC) lines fail to differentiate
normally under the influence of 1,25(OH)2D3, despite normal levels
of the vitamin D receptor (VDR) (Ratnam et al, 1996); however, 24-
hydroxylase, which is one of the key enzymes in the metabolism of
vitamin D, is stimulated in its activity by 1,25(OH)2D3 in both NHK
and SCC (Bikle et al, 1991). To examine the inducibility of human
PLC-γ1 transcription by 1,25(OH)2D3 in SCC lines, we transiently
transfected the SCC4 cell line derived from a carcinoma of human
tongue and the SCC12B2 cell line derived from a carcinoma of human
facial epidermis with human PLC-γ1 promoter-luciferase constructs or
human 24-hydroxylase promoter-luciferase constructs. We found that
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the VDRE in the human PLC-γ1 gene was not responsive to
1,25(OH)2D3, all-trans retinoic acid (all-trans RA), or their combina-
tion in SCC4 and SCC12B2 cells, unlike the VDRE in the human
24-hydroxylase gene. Correspondingly, the PLC-γ1 mRNA was upreg-
ulated by 1,25(OH)2D3 synergistic with all-trans RA in NHK, but
not in SCC4 and SCC12B2 cells; however, the DNA mobility shift
assay showed that both the VDR and the retinoic acid receptor (RAR)
bound to the human PLC-γ1 VDRE in nuclear extracts from NHK,
SCC4 and SCC12B2 cells indicating that the defect in transcriptional
regulation in SCC4 and SCC12B2 cells lies elsewhere.
MATERIALS AND METHODS
Cell culture NHK were isolated from neonatal human foreskins and grown
in serum free keratinocyte growth medium (KGM, Clonetics, San Diego, CA;
Pillai et al, 1988). Briefly, keratinocytes were isolated from newborn human
foreskins by trypsinization (0.25% tyrosine, 4°C, overnight), and primary
cultures were established in KGM containing 0.07 mM calcium. Second passage
keratinocytes were plated with KGM plus 0.03 mM calcium for the experiments.
SCC4 and SCC12B2 cells were plated under the same conditions as were NHK.
Northern hybridization Total RNA was isolated from NHK, SCC4, and
SCC12B2 cells treated with 1,25(OH)2D3 at a final concentration of 10
–9 M,
all-trans RA at a final concentration of 10–6 M, or vehicle (ethanol) for 24 h,
using STAT-60 kitTM (Tel-Test ‘‘B,’’ Friendswood, TX), according to the
procedures recommended by the manufacturer. The isolated RNA (60 µg
loaded in each lane) was electrophoresed through a 0.8% agarose-formaldehyde
gel, transferred to a nylon membrane (Hybond-N1; Amersham, Arlington
Heights, IL) using a PosiBlot 30–30 Pressure Blotter (Stratagene, La Jolla, CA),
and immobilized by baking the membrane at 80°C for 2 h. The human PLC-
γ1 cDNA probe (gift from Dr. John Imboden, University of California, San
Francisco, CA) was labeled with 32P-dCTP (Amersham) by Random Prime-
IT, II labeling kit (Stratagene), and purified by NucTrap Probe Purification
Columns (Stratagene). The membrane was prehybridized and hybridized in
5 3 sodium citrate/chloride buffer, 5 3 Denhardt’s solution, 0.5% sodium
dodecyl sulfate, and 20 µg salmon sperm DNA per ml with the 32P labeled
human PLC-γ1 cDNA. Following hybridization at 65°C overnight, the
membrane was washed in solutions with decreasing ionic strength and increasing
temperature, to a final stringency of 0.1 3 sodium citrate/chloride buffer, 0.1%
sodium dodecyl sulfate, at 65°C. The [32P]cDNA-mRNA hybrids were
visualized by exposing to X-ray film and quantitated by NIH Image. The
human PLC-γ1 mRNA was normalized to the levels of 18S ribosomal RNA
in the same RNA blots as determined by rehybridization of the filter with a
32P-end labeled cDNA for 18S RNA.
DNA transfection and luciferase assay The NHK, SCC4, and SCC12B2
cells were transfected with PLC-γ1-luciferase chimeric plasmids (Xie and Bikle,
1997) using a polybrene method 24 h after plating cells in 60 mm culture
dishes (Jiang et al, 1991). Cells were cotransfected with 0.2 µg of pRSVβ-gal
(Carroll and Taichman, 1992), a β-galactosidase expression vector that contains
a β-galactosidase gene that is driven by a Rous Sarcoma Virus promoter and
enhancer, which was used as an internal control to normalize for transfection
efficiency. 1,25(OH)2D3 and/or all-trans RA was added to the cells 24 h after
transfection. The final concentration of 1,25(OH)2D3 was 10
–9 M. The final
concentration of all-trans RA was 10–6 M. The same amount of ethanol
(vehicle) was added to the control plates. The final concentration of the ethanol
was 1% in the culture medium. Cells were harvested 24 h after addition of
1,25(OH)2D3. The cells were lysed and the cell extracts were assayed for
luciferase activities using a Luciferase Assay System (Promega, Madison, WI). The
β-galactosidase activities were assayed using a Galacto-LightTM kit (TROPIX,
Bedford, MA). A pGL-3-control vector (Promega) containing SV40 promoter
and SV40 enhancer, which we have shown to be unresponsive to 1,25(OH)2D3,
was included in each transfection experiment as a control. Every experiment
was done in triplicate and was repeated at least three times.
DNA mobility shift assay The nuclear extracts were made from NHK,
SCC4, and SCC12B2 cells according to the method described by Abmayr and
Workman (1994). Synthetic oligonucleotides used for the DNA mobility shift
assay were end-labeled by T4 polynucleotide kinase. The DNA-protein reactions
were performed in a total of 17 µl: nuclear extracts (12 µg protein) were
incubated with 2 µg of poly (dI:dC) (Pharmacia, Piscataway, NJ) and 10,000
cpm of 32P labeled probe in 10 ml binding buffer (20 mM HEPES, pH 7.9,
20% glycerol, 50 mM KCl, 0.5 mM dithiothreitol) at 30°C for 25 min.
Unlabeled competitors were added before incubation. In the super gel-shift
reaction, a polyclonal anti-VDR antibody or polyclonal RAR-γ1 antibody
(Affinity Bioreagents, Golden, CO) was added to the DNA-protein reaction
and incubated for an additional 25 min. Protein-DNA complexes were
Figure 1. The human PLC-γ1 mRNA level in NHK, SCC4, and
SCC12B2 cells in the presence or absence of 1,25(OH)2D3 and/or all-
trans RA. NHK, SCC4, and SCC12B2 cells were grown to preconfluence in
KGM containing 0.03 mM calcium, at which point 1,25(OH)2D3 (VD), all-
trans RA, or the same amount of vehicle (ethanol) was added. The cultures
were maintained for 24 h, and the cells harvested for RNA. The RNA was
isolated, electrophoresed, and blotted on to a membrane. The membrane was
hybridized with the probes for human PLC-γ1 cDNA and 18S RNA (a, c).
The resultant autoradiographs were scanned, and the ratios of PLC-γ1/18S
plotted (b, d).
electrophoresed in a 6% nondenaturing polyacrylamide gel in 1 3 gel shift
running buffer (50 mM Tris, 380 mM glycerin, 2 mM ethylenediamine
tetraacetic acid, pH 8.5).
RESULTS
Human PLC-γ1 mRNA was induced by 1,25(OH)2D3 in NHK,
but not in SCC4 and SCC12B2 cells Previous studies in our
laboratory showed that the effect of 1,25(OH)2D3 on the human PLC-
γ1 mRNA expression was biphasic. The peak stimulation was at
10–10–10–9 M (Pillai et al, 1995). This study showed that the mRNA
for PLC-γ1 in NHK was induced over 2-fold by 1,25(OH)2D3 (10–9
M) or all-trans RA (10–6 M), and 6-fold by their combination. In
contrast, the mRNA level for PLC-γ1 in SCC4 and SCC12B2 cells
did not change after the treatment of 1,25(OH)2D3 (10
–9 M) or all-
trans RA (10–6 M), or their combination. The basal mRNA levels in
SCC4 and SCC12B2 cells were much higher than in NHK in the
absence of 1,25(OH)2D3 (Fig 1). In other experiments, the mRNA
level in either NHK or SCC4 cells was not increased by all-trans RA
at a concentration of 10–8 M, whereas, as for the higher dose of all-
trans RA described above, the mRNA level for PLC-γ1 was increased
up to 6-fold by the combination of 1,25(OH)2D3 (10
–9 M) and all-
trans RA (10–8 M) in NHK; no stimulation was seen in SCC4 cells
(data not shown).
The VDRE in the human PLC-γ1 promoter is induced by
1,25(OH)2D3 and all-trans RA in NHK but not in SCC4 and
SCC12B2 cells Nine constructs containing nine deletional fragments
spanning 1135 bp to –877 bp in the 59 flanking region of the human
PLC-γ1 gene (Xie and Bikle, 1997) were transfected into NHK or
SCC4 and SCC12B2 cells in the presence or absence of 1,25(OH)2D3
(Fig 2a, b) The profile of the basal promoter activity obtained from
the nine constructs transfected into SCC4 cells is different from that
transfected into NHK. Deletions to –748 bp stimulated basal activity
in SCC4 cells but had no effect in NHK. When the 59 deletions
reached –613 bp, the promoter activity was greatly reduced in SCC4
cells, but not in NHK. The constructs containing the fragment 1135
to –877 or 1135 to –828 were responsive to 1,25(OH)2D3 when
transfected into NHK, but no response was seen when transfected into
SCC4 cells. The construct containing the human PLC-γ1 VDRE,
–786 bp to –803 bp in the human PLC-γ1 promoter (Xie and Bikle,
1997) linked to an SV40 promoter, showed a 2-fold increase by
1,25(OH)2D3 at a concentration of 10
–9 M in promoter activity, which
was potentiated by all-trans RA at a concentration of 10–6 M when
transfected into NHK (Fig 2c). All-trans RA at a concentration of
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Figure 2. The human PLC-γ1 promoter activities in NHK, SCC4, and
SCC12B2 cells in the presence or absence of 1,25(OH)2D3 and/or all-
trans RA. Nine 59 deletional fragments spanning from 1135 bp to –877 bp
in the human PLC-γ1 gene were ligated to the luciferase gene in a pGL-3-
basic vector. The fragment –768 to –803 was ligated to the SV40 promoter
and luciferase gene in a pGL-3-promoter vector. The construct containing the
SV40 promoter and SV40 enhancer was used as a control that is known not to
be induced by 1,25(OH)2D3. The constructs were transfected into NHK (a)
or SCC4 (b) as described in Materials and Methods. The luciferase activities were
measured following 24 h exposure to 1,25(OH)2D3 (VD) at a final concentration
of 10–9 M or vehicle, divided by β-galactosidase activity, and expressed as the
percentage of activity of the construct containing SV40 promoter and SV40
enhancer in the absence of 1,25(OH)2D3. The activity obtained with the pGL-
3-basic vector showed the vector background. A similar experiment was
performed in NHK (c), SCC4 (d), and SCC12B2 (e) cells transfected with
constructs containing the human PLC-γ1 gene fragment –768 to –803 in the
presence or absence of 1,25(OH)2D3 and/or all-trans RA. The results are
normalized to β-galactosidase activity. A construct containing the vitamin D
responsive region at –143 to –293 in the human 24-hydroxylase gene (24-
hydroxylase) was used as a positive control.
10–8 M had no effect on the promoter activity (data not shown);
however, no increase was found when transfected into SCC4 (Fig 2d)
and SCC12B2 cells (Fig 2e). SR11246, a retinoid 3 receptor (RXR)
selective analog, had no effect on the human PLC-γ1 VDRE in either
NHK or SCC4 cells (data not shown). The vitamin D responsive
region at –143 to –293 in the human 24-hydroxylase gene (Chen and
DeLuca, 1995), subcloned into the pGL-3-promoter vector, was used
as a positive control in the transfection experiments. In contrast to the
PLC-γ1 VDRE, the 24-hydroxylase VDRE construct showed a 2–3-
fold induction by 1,25(OH)2D3 in NHK, SCC4, and SCC12B2 cells,
and a 2-fold induction by all-trans RA in SCC4 and SCC12B2 cells,
but not in NHK (Fig 2c, d, e).
Both the VDR and the RAR in SCC4 and SCC12B2 cells bind
to the VDRE in the human PLC-γ1 gene To examine if the
VDR in SCC4 and SCC12B2 cells is able to bind the VDRE in the
human PLC-γ1 gene, the nuclear extracts isolated from NHK, SCC4,
or SCC12B2 cells were incubated with a 38 bp oligonucleotide
containing the direct repeat-6 (DR6) type VDRE (AGGT-
CAgaccacTGGACA) of the human PLC-γ1 gene (Xie and Bikle,
1997) in a DNA mobility shift assay. The results showed that a single
main complex formed after the incubation of the oligonucleotide with
the nuclear extracts isolated from NHK, SCC4, or SCC12B2 cells.
Figure 3. The binding of VDR in NHK, SCC4, and SCC12B2 cells with
fragments of the 59 flanking region of the human PLC-γ1 gene. Binding
of the human PLC-γ1 gene fragment –786 to –803 containing a DR6 type
VDRE with the VDR or RAR in NHK, SCC4, and SCC12B2 cells.
The arrows indicate VDR-RAR-DNA and antibodies-VDR-RAR-DNA
complexes. VDR-Ab, anti-VDR antibody; RAR-γ1-Ab, anti-retinoic acid
receptor antibody; NHK, normal human keratinocytes; SCC4, SCC4 cells;
SCC12B2, SCC12B2 cells.
The binding complex was shifted to a higher molecular form upon
the addition of an antibody specific to VDR or an antibody specific
to RARγ1 (Fig 3). Antibodies to RXRα had no effect (Fig 3). The
results indicate that the VDR and RAR-γ1 in SCC4 and SCC12B2
cells bind VDRE in the human PLC-γ1 gene, similarly to that in NHK.
DISCUSSION
The PLC-γ1 protein and mRNA expression are upregulated by
1,25(OH)2D3 in human keratinocytes (Pillai et al, 1995). This regulation
takes place at the transcriptional level with the 1,25(OH)2D3 receptor
binding to a DR6 type VDRE in the promoter (Xie and Bikle, 1997).
SCC are not induced to differentiate by 1,25(OH)2D3 in terms
of transglutaminase or involucrin production or cornified envelope
formation, despite normal levels of the VDR. These results indicate
that the mediators of 1,25(OH)2D3 action on gene expression other
than the VDR may be missing or defective in SCC4 cells (Ratnam
et al, 1996). In this study, we extended these observations by examining
the human PLC-γ1 mRNA level and promoter activities in the
presence or absence of 1,25(OH)2D3 in NHK, SCC4, and SCC12B2
cells. Our results indicate that PLC-γ1 mRNA expression and the
VDRE in the human PLC-γ1 promoter are not regulated by
1,25(OH)2D3 in SCC4 and SCC12B2 cells, unlike that in NHK;
however, this is not due to a universal failure of 1,25(OH)2D3 to act
on SCC4 and SCC12B2 cells because the 24-hydroxylase VDRE was
normally regulated by 1,25(OH)2D3 in these cells. These data suggest
that the inability of the human PLC-γ1 promoter in SCC4 and
SCC12B2 cells to respond to 1,25(OH)2D3 could be due to a selective
defect in the ability of the VDR to activate the VDRE in the human
PLC-γ1 promoter.
An interaction of VDR with RAR has been reported in the DR6
type VDRE in the human osteocalcin gene. This VDRE is not only
responsive to 1,25(OH)2D3, but also to all-trans RA (Schu¨le et al,
1990). In this report, the DR6 type VDRE located between –786 bp
and –803 bp upstream from the transcriptional start site in the human
PLC-γ1 gene is functional in NHK, but not in SCC4 and SCC12B2
cells. The promoter activities as well as the PLC-γ1 mRNA level in
NHK, but not in SCC4 and SCC123B2 cells, were increased by either
1,25(OH)2D3 or all-trans RA, and synergistically induced by the
combination of both. In contrast, the construct containing the DR3
type VDRE in the human 24-hydroxylase gene was found to be
responsive to 1,25(OH)2D3 in NHK, SCC4, and SCC12B2 cells,
but responsive to all-trans RA only in SCC4 and SCC12B2 cells.
Furthermore, when the interaction of 1,25(OH)2D3 and RA on the
expression of the differentiating markers involucrin and transglutaminase
was evaluated, RA blocked the increase in involucrin and transglutamin-
ase mRNA induced by 1,25(OH)2D3 (Gibson et al, 1997). At this
point the mechanism by which 1,25(OH)2D3 and all-trans RA regulate
VOL. 110, NO. 5 MAY 1998 VITAMIN D-RESPONSIVE ELEMENTS, KERATINOCYTES 733
the expression of involucrin and transglutaminase is not clear. The
differential effect of RA on the stimulation by 1,25(OH)2D3 of PLC-
γ1 versus involucrin and transglutaminase suggests different mechanisms.
This is an area of particular interest in our laboratory. The mechanisms
underlying the differential response of a gene to an activator like
1,25(OH)2D3 and RA within different cells, or even within the same
cells at different stages of differentiation, remain elusive. Selective loss
of such mechanisms during transformation to the malignant state is of
particular interest.
The activation of vitamin D responsive genes by 1,25(OH)2D3 is
through the VDR binding to its VDRE. VDR homodimers and
VDR-RAR heterodimers have been reported to bind to DR6 type
VDRE (Carlberg, 1993; Carlberg et al, 1993; Schra¨der et al, 1993,
1994). Our data indicate that all NHK, SCC4, and SCC12B2 cells
contain VDR and RAR-γ1 capable of binding to the DR6 type
VDRE in the human PLC-γ1 gene; however, nuclear receptors such
as VDR interact with additional coactivating or silencing factors in
addition to RXR or RAR to mediate activation and repression of
gene expression (Cavailles et al, 1994; Halachmi et al, 1994; Baniahmad
et al, 1995; Ho¨rlein et al, 1995; Chen and Evans, 1995; Kurokawa
et al, 1995; Kamei et al, 1996; Chakravarti et al, 1996). Identifying
such cofactors is expected to provide important clues for the selective
failure of SCC4, SCC12B2, and other transformed squamous cell
lines to respond to the anti-proliferating, prodifferentiating actions of
1,25(OH)2D3.
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